Methods: Exosomes were extracted from iPSC culture supernatants using ... Cambridge, UK), and recombinant anti-calnexin antibody (Abcam, Cambridge, UK), all diluted 1:1000 on a shaking platform. After ...

Multidrug-resistant bacteria pose a major threat to human health. Manipulation of bacterial genes at the transcriptional ...

Temporomandibular joint osteoarthritis (TMJOA) is a debilitating condition that causes severe joint pain, restricted mobility ...

Inspired by a recent post by Dr. Ardeshir Bayat on LinkedIn, exosomes have gained attention in the skincare world as a ...

This segment will highlight Esphera SynBio's groundbreaking work in developing next-generation exosome-based therapeutics and vaccines. This innovative technology uses modified exosomes—tiny ...

Researchers from SRM Institute of Science and Technology, led by Dr. KN Aruljothi, have published a study in ExRNA ...

Mental health professionals no longer diagnose ADD. Instead, they diagnose one of three types of ADHD: inattentive, hyperactive-impulsive, or combined. Attention deficit hyperactivity disorder ...

A BMI Korea spokesperson added: “This agreement positions BMI Korea as a leader in exosome-based therapeutics. By securing one of the most advanced pipelines in the industry, we are poised to achieve ...

α-LAMP1 (Ab24170-Abcam), α-CD63 (sc5275-Santa Cruz Biotech.), α-synthenin (Ab133267-Abcam), α-CALNEXIN (NB100-1965 – Novus Biologicals), α-GAPDH (MAB-374 - Merck-Millipore) used as a loading control.

Introduction: Prostate cancer (PC) is a leading cause of cancer-related deaths among men, often progressing to castration-resistant prostate cancer (CRPC) after androgen deprivation therapy (ADT). A ...